Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 142 articles:
HTML format
Text format



Single Articles


    August 2017
  1. ZIZZO MG, Serio R
    Therapeutic Potential of the Gabaergic System in Ulcerative Colitis: Current Status and Perspectives.
    Dig Dis Sci. 2017 Aug 5. doi: 10.1007/s10620-017-4709.
    PubMed     Text format    


  2. CARRASCO A, Fernandez-Banares F
    Th1 Pathway: The Missing Link Between Inflammatory Bowel Disease and Microscopic Colitis?
    Dig Dis Sci. 2017 Aug 3. doi: 10.1007/s10620-017-4692.
    PubMed     Text format    


  3. ALLOCCA M, Fiorino G, Danese S
    Biosimilar Drugs for Inflammatory Bowel Disease: Is Similar Good Enough?
    Dig Dis Sci. 2017 Aug 3. doi: 10.1007/s10620-017-4693.
    PubMed     Text format    


  4. KAMAT N, Ganesh Pai C, Surulivel Rajan M, Kamath A, et al
    Cost of Illness in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Aug 1. doi: 10.1007/s10620-017-4690.
    PubMed     Text format     Abstract available


    July 2017
  5. MOURAD FH, Yau Y, Wasinger VC, Leong RW, et al
    Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.
    Dig Dis Sci. 2017 Jul 17. doi: 10.1007/s10620-017-4673.
    PubMed     Text format     Abstract available


  6. SARTINI A, Gitto S, Villa E
    Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?
    Dig Dis Sci. 2017 Jul 4. doi: 10.1007/s10620-017-4665.
    PubMed     Text format    


    June 2017
  7. AGGARWAL S, Ahuja V, Paul J
    Attenuated GABAergic Signaling in Intestinal Epithelium Contributes to Pathogenesis of Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 30. doi: 10.1007/s10620-017-4662.
    PubMed     Text format     Abstract available


  8. SMITS LJT, Grelack A, Derikx LAAP, de Jong DJ, et al
    Long-Term Clinical Outcomes After Switching from Remicade(R) to Biosimilar CT-P13 in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 30. doi: 10.1007/s10620-017-4661.
    PubMed     Text format     Abstract available


  9. ARGUELLES-ARIAS F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, et al
    Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
    Dig Dis Sci. 2017 Jun 28. doi: 10.1007/s10620-017-4657.
    PubMed     Text format    


  10. KIM ES, Kim KO, Jang BI, Kim EY, et al
    Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 21. doi: 10.1007/s10620-017-4634.
    PubMed     Text format     Abstract available


  11. ELURI S, Parian AM, Limketkai BN, Ha CY, et al
    Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 19. doi: 10.1007/s10620-017-4652.
    PubMed     Text format     Abstract available


  12. LIU L, Li X
    NLRP3 Inflammasome in Inflammatory Bowel Disease: Friend or Foe?
    Dig Dis Sci. 2017 Jun 19. doi: 10.1007/s10620-017-4650.
    PubMed     Text format    


  13. JUNG YS, Han M, Kim WH, Park S, et al
    Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
    Dig Dis Sci. 2017 Jun 7. doi: 10.1007/s10620-017-4640.
    PubMed     Text format     Abstract available


  14. FRIEDMAN S
    Gestational Weight Gain: A New Factor Influencing Pregnancy Outcomes in Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 2. doi: 10.1007/s10620-017-4635.
    PubMed     Text format    


  15. LI J, Ueno A, Iacucci M, Fort Gasia M, et al
    Crossover Subsets of CD4+ T Lymphocytes in the Intestinal Lamina Propria of Patients with Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 1. doi: 10.1007/s10620-017-4596.
    PubMed     Text format     Abstract available


    May 2017
  16. MILLER TL, Lee D, Giefer M, Wahbeh G, et al
    Nutritional Therapy in Very Early-Onset Inflammatory Bowel Disease: A Case Report.
    Dig Dis Sci. 2017 May 27. doi: 10.1007/s10620-017-4616.
    PubMed     Text format     Abstract available


  17. TASSON L, Canova C, Vettorato MG, Savarino E, et al
    Influence of Diet on the Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 May 26. doi: 10.1007/s10620-017-4620.
    PubMed     Text format     Abstract available


  18. RINAWI F, Assa A, Bashir H, Peleg S, et al
    Clinical and Phenotypic Differences in Inflammatory Bowel Disease Among Arab and Jewish Children in Israel.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4623.
    PubMed     Text format     Abstract available


  19. ZULLOW S, Jambaulikar G, Rustgi A, Quezada S, et al
    Risk Factors for Vitamin D Deficiency and Impact of Repletion in a Tertiary Care Inflammatory Bowel Disease Population.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4614.
    PubMed     Text format     Abstract available


  20. LAZARIDIS LD, Pistiki A, Giamarellos-Bourboulis EJ, Georgitsi M, et al
    Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4609.
    PubMed     Text format     Abstract available


    April 2017
  21. MEIGHANI A, Hart BR, Bourgi K, Miller N, et al
    Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 27. doi: 10.1007/s10620-017-4580.
    PubMed     Text format     Abstract available


  22. SAEZ-GONZALEZ E, Moret I, Alvarez-Sotomayor D, Diaz-Jaime FC, et al
    Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 21. doi: 10.1007/s10620-017-4577.
    PubMed     Text format     Abstract available


  23. JIANG Y, Lin O, Sinha SR
    Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure.
    Dig Dis Sci. 2017 Apr 17. doi: 10.1007/s10620-017-4574.
    PubMed     Text format     Abstract available


  24. PIECHOTA-POLANCZYK A, Wlodarczyk M, Sobolewska-Wlodarczyk A, Jonakowski M, et al
    Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
    Dig Dis Sci. 2017 Apr 8. doi: 10.1007/s10620-017-4568.
    PubMed     Text format     Abstract available


  25. CAO B, Zhou X, Ma J, Zhou W, et al
    Role of MiRNAs in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 8. doi: 10.1007/s10620-017-4567.
    PubMed     Text format     Abstract available


  26. ULLMAN TA, Itzkowitz SH
    Prognosis of Colorectal Cancer in Inflammatory Bowel Disease: Data from a State Registry.
    Dig Dis Sci. 2017 Apr 3. doi: 10.1007/s10620-017-4557.
    PubMed     Text format    


  27. HIRTEN R, Sands BE, Cohen BL
    The Whys and Hows of Fourth-Year Inflammatory Bowel Disease Fellowships.
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4555.
    PubMed     Text format    


  28. SOFIA MA, Rubin DT
    The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions.
    Dig Dis Sci. 2017;62:833-842.
    PubMed     Text format     Abstract available


  29. BENET-CAMPOS C, Cuellar C, Garcia-Ballesteros C, Zamora V, et al
    Determination of Anti-Anisakis Simplex Antibodies and Relationship with alphabeta and gammadelta Lymphocyte Subpopulations in Patients with Crohn's Disease.
    Dig Dis Sci. 2017;62:934-943.
    PubMed     Text format     Abstract available


  30. CAO Y, Ding Z, Han C, Shi H, et al
    Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2017;62:851-860.
    PubMed     Text format     Abstract available


    March 2017
  31. ALLEGRETTI JR, Barnes EL, Stevens B, Storm M, et al
    Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab.
    Dig Dis Sci. 2017 Mar 29. doi: 10.1007/s10620-017-4549.
    PubMed     Text format     Abstract available


  32. BENGTSON MB, Martin CF, Aamodt G, Vatn MH, et al
    Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort.
    Dig Dis Sci. 2017 Mar 22. doi: 10.1007/s10620-017-4547.
    PubMed     Text format     Abstract available


  33. KHAN N, Patel D, Shah Y, Yang YX, et al
    A Novel Model for Predicting Incident Moderate to Severe Anemia and Iron Deficiency in Patients with Newly Diagnosed Ulcerative Colitis.
    Dig Dis Sci. 2017 Mar 11. doi: 10.1007/s10620-017-4512.
    PubMed     Text format     Abstract available


  34. ARGUELLES-ARIAS F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, et al
    Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
    Dig Dis Sci. 2017 Mar 9. doi: 10.1007/s10620-017-4511.
    PubMed     Text format     Abstract available


  35. CARR RM, Patel A, Bownik H, Oranu A, et al
    Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4495.
    PubMed     Text format     Abstract available


  36. BOLTIN D, Kamenetsky Z, Perets TT, Snir Y, et al
    Circulating Bone Marrow-Derived CD45-/CD34+/CD133+/VEGF+ Endothelial Progenitor Cells in Adults with Crohn's Disease.
    Dig Dis Sci. 2017;62:633-638.
    PubMed     Text format     Abstract available


    February 2017
  37. RAI T, Choudhury BN, Kedia S, Bopanna S, et al
    Short-Term Clinical Response to Corticosteroids Can Predict Long-Term Natural History of Ulcerative Colitis: Prospective Study Experience.
    Dig Dis Sci. 2017 Feb 4. doi: 10.1007/s10620-017-4450.
    PubMed     Text format     Abstract available


  38. NARULA N, Cooray M, Anglin R, Muqtadir Z, et al
    Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn's Disease in Remission: A Pilot Randomized Double-Blind Controlled Study.
    Dig Dis Sci. 2017;62:448-455.
    PubMed     Text format     Abstract available


  39. BODELIER AG, Jonkers D, van den Heuvel T, de Boer E, et al
    High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.
    Dig Dis Sci. 2017;62:465-472.
    PubMed     Text format     Abstract available


  40. KOTZE PG, Saab MP, Saab B, da Silva Kotze LM, et al
    Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.
    Dig Dis Sci. 2017;62:456-464.
    PubMed     Text format     Abstract available


    January 2017
  41. SCAIOLI E, Sartini A, Liverani E, Digby RJ, et al
    Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch-Anal Anastomosis for Ulcerative Colitis.
    Dig Dis Sci. 2017 Jan 21. doi: 10.1007/s10620-017-4454.
    PubMed     Text format     Abstract available


  42. LEE HS, Lim YJ, Shim KN, Moon CM, et al
    Diagnostic Value of Small Bowel Capsule Endoscopy in Isolated Ileitis: A CAPENTRY Study.
    Dig Dis Sci. 2017;62:180-187.
    PubMed     Text format     Abstract available


  43. SRIDHAR A, Cwiak CA, Kaunitz AM, Allen RH, et al
    Contraceptive Considerations for Women with Gastrointestinal Disorders.
    Dig Dis Sci. 2017;62:54-63.
    PubMed     Text format     Abstract available


  44. STEVENS BW, Borren NZ, Velonias G, Conway G, et al
    Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2017;62:197-206.
    PubMed     Text format     Abstract available


  45. FORTINSKY KJ, Kevans D, Qiang J, Xu W, et al
    Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease.
    Dig Dis Sci. 2017;62:188-196.
    PubMed     Text format     Abstract available


  46. XIE M, Qin H, Luo Q, He X, et al
    Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.
    Dig Dis Sci. 2017;62:115-123.
    PubMed     Text format     Abstract available


    December 2016
  47. TAKAHARA I, Takeshima F, Ichikawa T, Matsuzaki T, et al
    Prevalence of Restless Legs Syndrome in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4420.
    PubMed     Text format     Abstract available


  48. KORELITZ BI
    Enduring Value of Thiopurines for Inflammatory Bowel Disease Therapy.
    Dig Dis Sci. 2016 Dec 26. doi: 10.1007/s10620-016-4419.
    PubMed     Text format    


  49. TAN MC, El-Serag HB, Hou JK
    Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016 Dec 23. doi: 10.1007/s10620-016-4414.
    PubMed     Text format     Abstract available


  50. BERNSTEIN GR, Pickett-Blakely O
    De Novo Inflammatory Bowel Disease After Bariatric Surgery: A Case Series and Literature Review.
    Dig Dis Sci. 2016 Dec 23. doi: 10.1007/s10620-016-4412.
    PubMed     Text format    


  51. TAXONERA C, Iglesias E, Munoz F, Calvo M, et al
    Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  52. FEUERSTEIN JD, Sehgal P, Rao V, Malladi VR, et al
    Inflammatory Bowel Disease-Related Abstracts Presented at National Conferences in the USA Are Frequently Unpublished as Full Manuscripts.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  53. WANNHOFF A, Rupp C, Friedrich K, Knierim J, et al
    Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    November 2016
  54. PRIEUX-KLOTZ C, Nahon S, Amiot A, Sinayoko L, et al
    Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  55. LOPEZ-SANROMAN A, Carpio D, Calvet X, Romero C, et al
    Perceived Emotional and Psychological Impact of Ulcerative Colitis on Outpatients in Spain: UC-LIFE Survey.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    October 2016
  56. PADHAN RK, Kedia S, Garg SK, Bopanna S, et al
    Long-Term Disease Course and Pregnancy Outcomes in Women with Inflammatory Bowel Disease: An Indian Cohort Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  57. LATUSHKO A, Ghazi LJ
    A Case of Thiopurine-Induced Acute Myocarditis in a Patient with Ulcerative Colitis.
    Dig Dis Sci. 2016.
    PubMed     Text format    


    September 2016
  58. BARNES EL, Goldin A, Winter RW, Collins E, et al
    Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  59. SUSKIND DL, Wahbeh G, Cohen SA, Damman CJ, et al
    Patients Perceive Clinical Benefit with the Specific Carbohydrate Diet for Inflammatory Bowel Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  60. ANDERSON AJ, Click B, Ramos-Rivers C, Babichenko D, et al
    Development of an Inflammatory Bowel Disease Research Registry Derived from Observational Electronic Health Record Data for Comprehensive Clinical Phenotyping.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    August 2016
  61. DOTAN I, Levy-Nissenbaum E, Chowers Y, Fich A, et al
    Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  62. CLEVELAND NK, Rodriquez D, Wichman A, Pan I, et al
    Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    July 2016
  63. OPSTELTEN JL, Beelen RM, Leenders M, Hoek G, et al
    Exposure to Ambient Air Pollution and the Risk of Inflammatory Bowel Disease: A European Nested Case-Control Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  64. SUBRAMANIAN V, Chatu S, Echterdiek F, Banerjee A, et al
    Patients with Endoscopically Visible Polypoid Adenomatous Lesions Within the Extent of Ulcerative Colitis Have an Increased Risk of Colorectal Cancer Despite Endoscopic Resection.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    June 2016
  65. STRIZ I
    B Cell-Activating Factor (BAFF) in Inflammatory Bowel Disease: BAFFling No Longer?
    Dig Dis Sci. 2016.
    PubMed     Text format    


    May 2016
  66. CARD TR, Langan SM, Chu TP
    Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  67. TALEBAN S, Stewart KO, Li DK, Singh P, et al
    Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    April 2016
  68. ALSALEH A, Gaidos JK, Kang L, Kuemmerle JF, et al
    Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  69. LIU JJ, Kay TM, Davis EM, Lou Y, et al
    Epithelial Cell Extrusion Zones Observed on Confocal Laser Endomicroscopy Correlates with Immunohistochemical Staining of Mucosal Biopsy Samples.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  70. BAR-GIL SHITRIT A, Grisaru-Granovsky S, Ben Ya'acov A, Goldin E, et al
    Management of Inflammatory Bowel Disease During Pregnancy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  71. REICH JS, Farraye FA, Wasan SK
    Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  72. ZHANG P, Liu X, Guo A, Xiong J, et al
    B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  73. WENGROWER D, Koslowsky B, Peleg U, Mazuz B, et al
    Hearing Loss in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  74. CANKURTARAN E, Ekiz F, Hamamci M, Akinci H, et al
    Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn's Disease.
    Dig Dis Sci. 2016;61:1206-7.
    PubMed     Text format    


  75. GUNASEKEERA V, Mendall MA, Chan D, Kumar D, et al
    Treatment of Crohn's Disease with an IgG4-Guided Exclusion Diet: A Randomized Controlled Trial.
    Dig Dis Sci. 2016;61:1148-57.
    PubMed     Text format     Abstract available


  76. WILLIET N, Paul S, Peyrin-Biroulet L, Roblin X, et al
    Pharmacokinetics of Infliximab and Reduction of Treatment for Inflammatory Bowel Diseases.
    Dig Dis Sci. 2016;61:990-5.
    PubMed     Text format     Abstract available


  77. LEE D, Suskind D
    Individualized Food-Based Dietary Therapy for Crohn's Disease: Are We Making Progress?
    Dig Dis Sci. 2016;61:958-60.
    PubMed     Text format    


    March 2016
  78. MARTINS FS
    Fecal Microbiota Transplantation for Ulcerative Colitis: FoMenTing Change?
    Dig Dis Sci. 2016.
    PubMed     Text format    


  79. PAUL S, Shuja A, Tam I, Kim EM, et al
    Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    February 2016
  80. GARCIA-BOSCH O, Aceituno M, Ordas I, Etchevers J, et al
    Long-Term Follow-Up of Patients Treated with Infliximab for Ulcerative Colitis: Predictive Factors of Response-An Observational Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  81. OZA SS, Pabby V, Dodge LE, Hacker MR, et al
    Factors Associated with the Success of In Vitro Fertilization in Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  82. ADAR T, Shteingart S, Ben-Ya'acov A, Shitrit AB, et al
    The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  83. SAPIR T, Moreo K, Carter JD, Greene L, et al
    Continuing Medical Education Improves Gastroenterologists' Compliance with Inflammatory Bowel Disease Quality Measures.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  84. LEE NS, Pola S, Groessl EJ, Rivera-Nieves J, et al
    Opportunities for Improvement in the Care of Patients Hospitalized for Inflammatory Bowel Disease-Related Colitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  85. TIAN Z, Liu J, Liao M, Li W, et al
    Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  86. SOBOLEWSKA A, Wlodarczyk M, Stec-Michalska K, Fichna J, et al
    Mean Platelet Volume in Crohn's Disease Patients Predicts Sustained Response to a 52-Week Infliximab Therapy: A Pilot Study.
    Dig Dis Sci. 2016;61:542-9.
    PubMed     Text format     Abstract available


  87. TALEBAN S, Van Oijen MG, Vasiliauskas EA, Fleshner PR, et al
    Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn's Colitis.
    Dig Dis Sci. 2016;61:550-9.
    PubMed     Text format     Abstract available


    January 2016
  88. O'TOOLE A, Lucci M, Korzenik J
    Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDA.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  89. SHAPIRO JM, Hagin SE, Shah SA, Bright R, et al
    Corticosteroid Use in a Prospective, Community-Based Cohort of Newly Diagnosed Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  90. SUGIMOTO K, Ikeya K, Iida T, Kawasaki S, et al
    An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
    Dig Dis Sci. 2016;61:99-106.
    PubMed     Text format     Abstract available


    December 2015
  91. FEATHERS A, Yen T, Yun L, Strizich G, et al
    Internet Searches About Therapies Do Not Impact Willingness to Accept Prescribed Therapy in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  92. SENGUPTA N, Yee E, Feuerstein JD
    Colorectal Cancer Screening in Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  93. OKAFOR PN, Farraye FA, Okafor AT, Erim DO, et al
    Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn's Disease.
    Dig Dis Sci. 2015;60:3743-55.
    PubMed     Text format     Abstract available


    November 2015
  94. BARNES D, Kerner J
    Severe Lactic Acidosis in a Parenteral Nutrition-Dependent Teenager with Ulcerative Colitis.
    Dig Dis Sci. 2015.
    PubMed     Text format    


  95. LICHTENSTEIN GR, Gordon GL, Zakko S, Murthy U, et al
    Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  96. LICHTENSTEIN GR
    Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  97. ZOLLNER-SCHWETZ I, Herzog KA, Feierl G, Leitner E, et al
    The Toxin-Producing Pathobiont Klebsiella oxytoca Is Not Associated with Flares of Inflammatory Bowel Diseases.
    Dig Dis Sci. 2015;60:3393-8.
    PubMed     Text format     Abstract available


  98. TAKEYAMA H, Mizushima T, Iijima H, Shinichiro S, et al
    Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.
    Dig Dis Sci. 2015;60:3418-23.
    PubMed     Text format     Abstract available


    October 2015
  99. OU B, Zhao J, Guan S, Lu A, et al
    Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  100. KOUTROUMPAKIS E, Ramos-Rivers C, Regueiro M, Hashash JG, et al
    Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  101. MALATY HM, Sansgiry S, Artinyan A, Hou JK, et al
    Time Trends, Clinical Characteristics, and Risk Factors of Chronic Anal Fissure Among a National Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  102. THAPA SD, Hadid H, Usman M, Imam W, et al
    Predictors of Thiopurine Treatment Failure in Biologic-Naive Ulcerative Colitis Patients.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  103. ASHIZUKA S, Inatsu H, Kita T, Kitamura K, et al
    Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  104. QAZI T, Shah B, El-Dib M, Farraye FA, et al
    The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  105. GROVER Z, Lewindon P
    Two-Year Outcomes After Exclusive Enteral Nutrition Induction Are Superior to Corticosteroids in Pediatric Crohn's Disease Treated Early with Thiopurines.
    Dig Dis Sci. 2015;60:3069-74.
    PubMed     Text format     Abstract available


  106. TORKI M, Gholamrezaei A, Mirbagher L, Danesh M, et al
    Vitamin D Deficiency Associated with Disease Activity in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2015;60:3085-91.
    PubMed     Text format     Abstract available


    September 2015
  107. GAJENDRAN M, Umapathy C, Loganathan P, Hashash JG, et al
    Analysis of Hospital-Based Emergency Department Visits for Inflammatory Bowel Disease in the USA.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  108. PETAN T, Krizaj I
    Is iPLAbeta a Novel Target for the Development of New Strategies to Alleviate Inflammatory Bowel Disease?
    Dig Dis Sci. 2015.
    PubMed     Text format    


  109. ADAR T, Grisaru-Granovsky S, Ben Ya'acov A, Goldin E, et al
    Pregnancy and the Immune System: General Overview and the Gastroenterological Perspective.
    Dig Dis Sci. 2015;60:2581-9.
    PubMed     Text format     Abstract available


  110. ANDRADE P, Lopes S, Albuquerque A, Osorio F, et al
    Oral Lichen Planus in IBD Patients: A Paradoxical Adverse Effect of Anti-TNF-alpha Therapy.
    Dig Dis Sci. 2015;60:2746-9.
    PubMed     Text format     Abstract available


  111. VANDE CASTEELE N, Gils A
    Preemptive Dose Optimization Using Therapeutic Drug Monitoring for Biologic Therapy of Crohn's Disease: Avoiding Failure While Lowering Costs?
    Dig Dis Sci. 2015;60:2571-3.
    PubMed     Text format    


  112. STEENHOLDT C, Brynskov J, Thomsen OO, Munck LK, et al
    Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab.
    Dig Dis Sci. 2015;60:2762-70.
    PubMed     Text format     Abstract available


    August 2015
  113. JAMALI R
    Important Issues Regarding Serum 25-Hydroxy Vitamin D Measurement in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2015.
    PubMed     Text format    


  114. DEFILIPPIS EM, Tabani S, Warren RU, Christos PJ, et al
    Exercise and Self-Reported Limitations in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  115. WILSON A, Teft WA, Morse BL, Choi YH, et al
    Erratum to: Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format    


  116. KUO CJ, Yu KH, See LC, Chiu CT, et al
    The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study.
    Dig Dis Sci. 2015;60:2454-62.
    PubMed     Text format     Abstract available


  117. SHAH ED, Siegel CA, Chong K, Melmed GY, et al
    Patients with Crohn's Disease Are More Likely to Remain on Biologics than Immunomodulators: A Meta-Analysis of Treatment Durability.
    Dig Dis Sci. 2015;60:2408-18.
    PubMed     Text format     Abstract available


  118. RAFTERY T, Merrick M, Healy M, Mahmud N, et al
    Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn's Disease in Clinical Remission.
    Dig Dis Sci. 2015;60:2427-35.
    PubMed     Text format     Abstract available


    July 2015
  119. WILSON A, Teft WA, Morse BM, Choi YH, et al
    Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  120. TRINDADE IA, Ferreira C, Pinto-Gouveia J
    Ulcerative Colitis Symptomatology and Depression: The Exacerbator Role of Maladaptive Psychological Processes.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  121. SCALDAFERRI F, Vetrano S
    Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms.
    Dig Dis Sci. 2015;60:1873-5.
    PubMed     Text format    


  122. VEERAPPAN SG, Healy M, Walsh BJ, O'Morain CA, et al
    Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn's Disease.
    Dig Dis Sci. 2015;60:2119-29.
    PubMed     Text format     Abstract available


    June 2015
  123. GEORGE LA, Gadani A, Cross RK, Jambaulikar G, et al
    Psoriasiform Skin Lesions Are Caused by Anti-TNF Agents Used for the Treatment of Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  124. HRADSKY O, Copova I, Zarubova K, Durilova M, et al
    Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  125. O'TOOLE A, Nwanne O, Tomlinson T
    Inflammatory Bowel Disease Increases Risk of Adverse Pregnancy Outcomes: A Meta-Analysis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  126. TAXONERA C, Barreiro-de Acosta M, Calvo M, Saro C, et al
    Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  127. WU XW, Wu L, Ji HZ, Wang FY, et al
    Relationship Between Cytomegalovirus Infection and Steroid Resistance in Inflammatory Bowel Disease: A Meta-Analysis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  128. SAJJADI M, Gholamrezaei A, Daryani NE
    No association between serum adenosine deaminase activity and disease activity in Crohn's disease.
    Dig Dis Sci. 2015;60:1755-60.
    PubMed     Text format     Abstract available


  129. BAIRD AC, Lloyd F, Lawrance IC
    Prostaglandin E(2) and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function.
    Dig Dis Sci. 2015;60:1603-16.
    PubMed     Text format     Abstract available


    May 2015
  130. DEFILIPPIS EM, Kumar S
    Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  131. THAPA SD, Hadid H, Imam W, Hassan A, et al
    Persistent Reactive Thrombocytosis May Increase the Risk of Coronary Artery Disease Among Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  132. TOLSTANOVA G, Deng X, Ahluwalia A, Paunovic B, et al
    Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  133. BRUNO ME, Rogier EW, Arsenescu RI, Flomenhoft DR, et al
    Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  134. CARBONNEL F, Hugot JP
    Which Environmental Factors Cause IBD Relapses?
    Dig Dis Sci. 2015;60:1129-31.
    PubMed     Text format    


  135. KAMATA N, Oshitani N, Watanabe K, Watanabe K, et al
    Efficacy of concomitant elemental diet therapy in scheduled infliximab therapy in patients with Crohn's disease to prevent loss of response.
    Dig Dis Sci. 2015;60:1382-8.
    PubMed     Text format     Abstract available


  136. TURSI A, Elisei W, Picchio M, Giorgetti G, et al
    Accuracy of Rapid Fecal Calprotectin Test in Monitoring Inflammatory Bowel Diseases Under Treatment with TNFalpha Antagonists.
    Dig Dis Sci. 2015;60:1406-13.
    PubMed     Text format     Abstract available


  137. MALGRAS B, Pautrat K, Dray X, Pasquier P, et al
    Multidisciplinary management of gastrointestinal fibrotic stenosis in Crohn's disease.
    Dig Dis Sci. 2015;60:1152-68.
    PubMed     Text format     Abstract available


  138. WENZL HH, Primas C, Novacek G, Teml A, et al
    Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's disease.
    Dig Dis Sci. 2015;60:1414-23.
    PubMed     Text format     Abstract available


    April 2015
  139. BURRI E, Beglinger C, Lehmann FS
    Reply: To PMID 25344905.
    Dig Dis Sci. 2015;60:1109-10.
    PubMed     Text format    


  140. SHAH SA
    Predicting the Need for Imaging in IBD: Radiating Only Badness?
    Dig Dis Sci. 2015;60:813-5.
    PubMed     Text format    


  141. TAO Q, Wang B, Zheng Y, Jiang X, et al
    Vitamin D prevents the intestinal fibrosis via induction of vitamin D receptor and inhibition of transforming growth factor-beta1/Smad3 pathway.
    Dig Dis Sci. 2015;60:868-75.
    PubMed     Text format     Abstract available


  142. JUNG YS, Park DI, Hong SN, Kim ER, et al
    Predictors of Urgent Findings on Abdominopelvic CT in Patients with Crohn's Disease Presenting to the Emergency Department.
    Dig Dis Sci. 2015;60:929-35.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: